0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Biomedical Politics

Norman G. Levinsky, MD
JAMA. 1992;267(2):300. doi:10.1001/jama.1992.03480020110046.
Text Size: A A A
Published online

ABSTRACT

Do the enormous potential benefits of recombinant technology justify the risk of creating a lethal "Andromeda strain"? How big is the risk, anyway? Should society impede the progress of science by requiring expensive containment facilities?

During the past several decades, research has moved from Arrowsmith to Aerosmith, from the isolated scientist in an ivory tower to cacophony in the public arena about the costs, the values, and the achievements of modern biomedical science. In 1989 the Institute of Medicine convened a committee to study how decisions have been made about controversial biomedical issues and to make recommendations for improving the process. As a basis for the committee's discussion, the Institute commissioned six case studies of major decisions that demonstrate the interplay of experts and the general public, of scientists and government officials, and of strongly held societal opinions, such as those about abortion and scientific advances.

The cases range across

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();